Matches in SemOpenAlex for { <https://semopenalex.org/work/W2481453872> ?p ?o ?g. }
- W2481453872 abstract "Isolated growth hormone deficiency type II (IGHD II) is a rare genetic splicing disorder characterized by reduced growth hormone (GH) secretion and short stature. It is mainly caused by autosomal dominant-negative mutations within the growth hormone gene (GH-1) which results in missplicing at the mRNA level and the subsequent loss of exon 3, producing the 17.5-kDa GH isoform: a mutant and inactive GH protein that reduces the stability and the secretion of the 22-kDa GH isoform, the main biologically active GH form. At present, patients suffering from IGHD II are treated with daily injections of recombinant human GH (rhGH) in order to reach normal height. However, this type of replacement therapy, although effective in terms of growth, does not prevent the toxic effects of the 17.5-kDa mutant on the pituitary gland, which may eventually lead to other hormonal deficiencies. As the severity of the disease inversely correlates with the 17.5-kDa/22-kDa ratio, increasing the inclusion of exon 3 is expected to ameliorate disease symptoms. This review focuses on the recent advances in experimental and therapeutic strategies applicable to treat IGHD II in clinical and preclinical contexts. Several avenues for alternative IGHD II therapy will be discussed including the use of small interfering RNA (siRNA) and short hairpin RNA (shRNA) constructs that specifically target the exon 3-deleted transcripts as well as the application of histone deacetylase inhibitors (HDACi) and antisense oligonucleotides (AONs) to enhance full-length GH-1 transcription, correct GH-1 exon 3 splicing and manipulate GH pathway." @default.
- W2481453872 created "2016-08-23" @default.
- W2481453872 creator A5049607156 @default.
- W2481453872 creator A5077460315 @default.
- W2481453872 creator A5078327990 @default.
- W2481453872 date "2017-01-01" @default.
- W2481453872 modified "2023-09-22" @default.
- W2481453872 title "Targeting GH-1 splicing as a novel pharmacological strategy for growth hormone deficiency type II" @default.
- W2481453872 cites W1488584185 @default.
- W2481453872 cites W1492560350 @default.
- W2481453872 cites W1540119541 @default.
- W2481453872 cites W1585195212 @default.
- W2481453872 cites W1776427138 @default.
- W2481453872 cites W1964052811 @default.
- W2481453872 cites W1971643509 @default.
- W2481453872 cites W1981903626 @default.
- W2481453872 cites W1985536839 @default.
- W2481453872 cites W1989658917 @default.
- W2481453872 cites W1989696433 @default.
- W2481453872 cites W1989779376 @default.
- W2481453872 cites W1990210083 @default.
- W2481453872 cites W1990432677 @default.
- W2481453872 cites W1993301516 @default.
- W2481453872 cites W1997025763 @default.
- W2481453872 cites W2000725203 @default.
- W2481453872 cites W2000944427 @default.
- W2481453872 cites W2007508388 @default.
- W2481453872 cites W2012689549 @default.
- W2481453872 cites W2014559917 @default.
- W2481453872 cites W2018716607 @default.
- W2481453872 cites W2022285476 @default.
- W2481453872 cites W2024934554 @default.
- W2481453872 cites W2025864476 @default.
- W2481453872 cites W2035892401 @default.
- W2481453872 cites W2040673222 @default.
- W2481453872 cites W2045463208 @default.
- W2481453872 cites W2045732936 @default.
- W2481453872 cites W2047404721 @default.
- W2481453872 cites W2049585672 @default.
- W2481453872 cites W2053974882 @default.
- W2481453872 cites W2055488174 @default.
- W2481453872 cites W2061312813 @default.
- W2481453872 cites W2063318299 @default.
- W2481453872 cites W2067090328 @default.
- W2481453872 cites W2071746055 @default.
- W2481453872 cites W2073030003 @default.
- W2481453872 cites W2078427368 @default.
- W2481453872 cites W2080356693 @default.
- W2481453872 cites W2082236797 @default.
- W2481453872 cites W2087318282 @default.
- W2481453872 cites W2089728262 @default.
- W2481453872 cites W2090406972 @default.
- W2481453872 cites W2091338613 @default.
- W2481453872 cites W2092774801 @default.
- W2481453872 cites W2101481997 @default.
- W2481453872 cites W2107226581 @default.
- W2481453872 cites W2107964493 @default.
- W2481453872 cites W2109306311 @default.
- W2481453872 cites W2109936378 @default.
- W2481453872 cites W2114702977 @default.
- W2481453872 cites W2114716357 @default.
- W2481453872 cites W2117832356 @default.
- W2481453872 cites W2125946663 @default.
- W2481453872 cites W2126879257 @default.
- W2481453872 cites W2127022091 @default.
- W2481453872 cites W2127425834 @default.
- W2481453872 cites W2130763976 @default.
- W2481453872 cites W2130886644 @default.
- W2481453872 cites W2132148889 @default.
- W2481453872 cites W2135812210 @default.
- W2481453872 cites W2138351591 @default.
- W2481453872 cites W2138377745 @default.
- W2481453872 cites W2139919925 @default.
- W2481453872 cites W2141136134 @default.
- W2481453872 cites W2141370108 @default.
- W2481453872 cites W2144510218 @default.
- W2481453872 cites W2146577466 @default.
- W2481453872 cites W2149481067 @default.
- W2481453872 cites W2152909938 @default.
- W2481453872 cites W2159952204 @default.
- W2481453872 cites W2162215932 @default.
- W2481453872 cites W2163865122 @default.
- W2481453872 cites W2164826326 @default.
- W2481453872 cites W2168245331 @default.
- W2481453872 cites W2169104245 @default.
- W2481453872 cites W2170780799 @default.
- W2481453872 cites W2172169364 @default.
- W2481453872 cites W2321682596 @default.
- W2481453872 cites W2528946604 @default.
- W2481453872 cites W4252269989 @default.
- W2481453872 doi "https://doi.org/10.1016/j.bcp.2016.07.016" @default.
- W2481453872 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27457999" @default.
- W2481453872 hasPublicationYear "2017" @default.
- W2481453872 type Work @default.
- W2481453872 sameAs 2481453872 @default.
- W2481453872 citedByCount "2" @default.
- W2481453872 countsByYear W24814538722019 @default.
- W2481453872 crossrefType "journal-article" @default.
- W2481453872 hasAuthorship W2481453872A5049607156 @default.
- W2481453872 hasAuthorship W2481453872A5077460315 @default.